The Genomics Facility provides CSHL Cancer Center members with many of the powerful genomic tools and techniques that have become available over the last several years. The facility, which initially started as a fluorescence in situ hybridization (FISH0 facility for gene mapping, has rapidly evolved in concert with the field, continuously expanding and updating the services that it offers. The facility currently offers the following services to the CSHL community: 1) Gene mapping by radiation hybrid (human and mouse); 2) BAC library screen (human and mouse); 3) YAC library screen (human and mouse); 4) Quantitative PCR analysis (Q-PCR) to detect deletions or amplifications of particular genomic loci in primary tumor samples and/or tumor cell lines; and 5) Isolation of C. elegans deletion mutant strains. In the near future, the facility plans to also offer a cDNA microarray screening service. The facility is headed by Dr. Michael Hengartner, who took over upon the departure of Dr. Carol Greider. Dr. Diane Esposito is in charge of day-to- day management of the facility, which is staffed by two technicians: Mr. Another Buglino (100%) and Jianli Gong (50%). The facility has been very useful in helping CSHL Cancer Center members to identify and characterize candidate oncogenes and tumor suppressor genes, and therefore is highly relevant to the mission of the CSHL Cancer Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA045508-15S1
Application #
6501457
Study Section
Subcommittee G - Education (NCI)
Project Start
2001-08-01
Project End
2002-07-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
15
Fiscal Year
2001
Total Cost
$78,870
Indirect Cost
Name
Cold Spring Harbor Laboratory
Department
Type
DUNS #
065968786
City
Cold Spring Harbor
State
NY
Country
United States
Zip Code
11724
Krishnan, Navasona; Bonham, Christopher A; Rus, Ioana A et al. (2018) Harnessing insulin- and leptin-induced oxidation of PTP1B for therapeutic development. Nat Commun 9:283
Pommier, Arnaud; Anaparthy, Naishitha; Memos, Nicoletta et al. (2018) Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases. Science 360:
Krishnan, Navasona; Felice, Christy; Rivera, Keith et al. (2018) DPM-1001 decreased copper levels and ameliorated deficits in a mouse model of Wilson's disease. Genes Dev 32:944-952
Tiriac, Herve; Bucobo, Juan Carlos; Tzimas, Demetrios et al. (2018) Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment. Gastrointest Endosc 87:1474-1480
Nattestad, Maria; Goodwin, Sara; Ng, Karen et al. (2018) Complex rearrangements and oncogene amplifications revealed by long-read DNA and RNA sequencing of a breast cancer cell line. Genome Res 28:1126-1135
Connell, Claire M; Raby, Sophie E M; Beh, Ian et al. (2018) Cancer Immunotherapy Trials Underutilize Immune Response Monitoring. Oncologist 23:116-117
Wong, Mandy S; Kinney, Justin B; Krainer, Adrian R (2018) Quantitative Activity Profile and Context Dependence of All Human 5' Splice Sites. Mol Cell 71:1012-1026.e3
Snider, Justin M; Snider, Ashley J; Obeid, Lina M et al. (2018) Probing de novo sphingolipid metabolism in mammalian cells utilizing mass spectrometry. J Lipid Res 59:1046-1057
Stacchiotti, Silvia; Mir, Olivier; Le Cesne, Axel et al. (2018) Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma. Oncologist 23:62-70
Banito, Ana; Li, Xiang; Laporte, Aimée N et al. (2018) The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma. Cancer Cell 33:527-541.e8

Showing the most recent 10 out of 380 publications